Details

Autor(en) / Beteiligte

• Mulrooney, Daniel A
• Armstrong, Gregory T
• Huang, Sujuan
• Ness, Kirsten K
• Ehrhardt, Matthew J
• Joshi, Vijaya M
• Plana, Juan Carlos
• Soliman, Elsayed Z
• Green, Daniel M
• Srivastava, Deokumar
• Santucci, Aimee
• Krasin, Matthew J
• Robison, Leslie L
• Hudson, Melissa M

Titel

Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study

Ist Teil von

• Annals of internal medicine, 2016-01, Vol.164 (2), p.93

Ort / Verlag

United States

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Studies of cardiac disease among adult survivors of childhood cancer have generally relied on self-reported or registry-based data. To systematically assess cardiac outcomes among survivors of childhood cancer. Cross-sectional study. St. Jude Children's Research Hospital. 1853 adult survivors of childhood cancer, aged 18 years or older, who received cancer-related cardiotoxic therapy at least 10 years earlier. Baseline history and physical examination, fasting metabolic and lipid panels, echocardiography, electrocardiography, and 6-minute walk test. One half of the survivors (52.3%) were men with a median age of 8 years (range, 0 to 24 years) at cancer diagnosis and 31 years (range, 18 to 60 years) at evaluation. Cardiomyopathy was present in 7.4% survivors (newly identified at the time of evaluation in 4.7%), coronary artery disease in 3.8% (newly identified in 2.2%), valvular regurgitation or stenosis in 28.0% (newly identified in 24.8%), and conduction or rhythm abnormalities in 4.4% (newly identified in 1.4%). Nearly all survivors were asymptomatic. The prevalence of cardiac conditions increased with age at evaluation, ranging from 3% to 24% among survivors aged 30 to 39 years to 10% to 37% among those aged 40 years or older. In multivariable analysis, survivors exposed to anthracycline doses of 250 mg/m2 or more had greater odds of cardiomyopathy (odds ratio, 2.7 [95% CI, 1.1 to 6.9]) than those who were not exposed. Survivors exposed to heart radiation also had increased odds of cardiomyopathy (odds ratio, 1.9 [CI, 1.1 to 3.7]) compared with those who were not exposed. Radiation exposure greater than 1500 cGy with any anthracycline exposure conferred the greatest odds for valve findings. Sixty-one percent of survivors exposed to anthracycline chemotherapy or cardiac-directed radiation participated. A comparison group and longitudinal assessments were not available. Cardiovascular screening identified considerable subclinical disease among adult survivors of childhood cancer. National Cancer Institute, American Lebanese Syrian Associated Charities.